Try our beta test site
16 studies found for:    "Autoimmune hemolytic anemia"
Show Display Options
RSS Create an RSS feed from your search for:
"Autoimmune hemolytic anemia"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting A Safety and Efficacy Study of R935788 in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia (AIHA)
Condition: Warm Antibody Autoimmune Hemolytic Anemia
Intervention: Drug: Fostamatinib 150 mg bid
2 Recruiting Immunopathology of Autoimmune Hemolytic Anemia
Condition: Autoimmune Hemolytic Anemia
Intervention: Biological: blood samples
3 Recruiting Study the Role of T Lymphocytes in Autoimmune Hemolytic Anemia
Condition: Autoimmune Hemolytic Anemia
Intervention: Biological: blood sample
4 Active, not recruiting Rituximab in Auto-Immune Hemolytic Anemia
Condition: Warm Autoimmune Hemolytic Anemia
Interventions: Drug: rituximab (Mabthera®);   Drug: Placebo
5 Not yet recruiting Evaluating the Interest of Interleukine-2 for Patients With Active Warm Hemolytic Anemia Resistant to Conventional Treatment
Condition: Autoimmune Hemolytic Anemia
Intervention: Drug: Interleukine-2
6 Unknown  Efficacy and Safety of Levamisole Combined With Standard Prednisolone in Warm Antibody Autoimmune Hemolytic Anemia.
Conditions: Anemia;   Anemia, Hemolytic;   Anemia, Hemolytic, Autoimmune;   Hemolysis;   Hematologic Diseases;   Autoimmune Diseases;   Immune System Diseases;   Pathologic Processes
Interventions: Drug: levamisole;   Drug: Prednisone
7 Completed A Single-Arm Pilot Study With Low-Dose Rituximab Plus Standard Oral Prednisone In Idiopathic Autoimmune Hemolytic Anemia
Condition: Autoimmune Hemolytic Disease (Cold Type) (Warm Type)
Intervention: Drug: prednisone, low dose rituximab
8 Not yet recruiting A Safety Study of SYNT001 in Subjects With Chronic, Stable Warm Autoimmune Hemolytic Anemia (WAIHA)
Condition: Anemia, Hemolytic, Autoimmune
Intervention: Drug: SYNT001
9 Completed Bendamustine and Rituximab Combination Therapy for Cold Agglutinin Disease
Conditions: Cold Agglutinin Disease;   Autoimmune Hemolytic Anemia
Intervention: Drug: Bendamustine, Rituximab
10 Completed Combination Chemotherapy and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia (CLL) That Did Not Respond to Fludarabine, CLL With Autoimmune Haemolytic Anemia (AIHA) or Richter's Transformation (RT)
Condition: Chronic Lymphocytic Leukemia
Interventions: Biological: rituximab;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: prednisone;   Drug: vincristine sulfate
11 Completed Treatment of Autoimmune Thrombocytopenia (AITP)
Conditions: Autoimmune Disease;   Autoimmune Hemolytic Anemia;   Thrombocytopenia
Intervention: Device: Isolex 300i
12 Completed Prednisolone +/- Addition of Anti-CD20 Antibody, Rituximab, in Patients With Immune Hemolytic Anemia
Condition: Anemia, Hemolytic, Autoimmune
Interventions: Drug: prednisolone + mabthera;   Drug: Prednisolone
13 Recruiting Safety, Tolerability and Activity of TNT009 in Healthy Volunteers and Patients With Complement Mediated Disorders
Conditions: Bullous Pemphigoid (BP);   Cold Agglutinin Disease;   Warm Autoimmune Hemolytic Anemia;   End-stage Renal Disease (ESRD)
Interventions: Drug: TNT009;   Other: Placebo
14 Completed The RITAI Cohort: An Observational Study on Rituximab Off-label Use for Auto-immune Disorders
Conditions: Pemphigus;   Auto-immune Thrombocytopenic Purpura;   Hemolytic Auto-immune Anaemia;   Cold Agglutinin Disease;   Cryoglobulinemia
Intervention: Drug: Rituximab (MABTHERA® or RITUXAN®).
15 Completed Phase II Study of High-Dose Cyclophosphamide in Patients With Severe Autoimmune Hematologic Disease
Conditions: Anemia, Hemolytic, Autoimmune;   Felty Syndrome;   Purpura, Thrombocytopenic;   Autoimmune Diseases
Interventions: Drug: cyclophosphamide;   Drug: filgrastim
16 Unknown  Autologous Peripheral Blood Stem Cell Transplantation in Patients With Life Threatening Autoimmune Diseases
Conditions: Purpura, Schoenlein-Henoch;   Graft Versus Host Disease;   Anemia, Hemolytic, Autoimmune;   Rheumatoid Arthritis;   Churg-Strauss Syndrome;   Hypersensitivity Vasculitis;   Wegener's Granulomatosis;   Systemic Lupus Erythematosus;   Giant Cell Arteritis;   Pure Red Cell Aplasia;   Juvenile Rheumatoid Arthritis;   Polyarteritis Nodosa;   Autoimmune Thrombocytopenic Purpura;   Takayasu Arteritis
Interventions: Drug: anti-thymocyte globulin;   Drug: cyclophosphamide;   Drug: cyclosporine;   Drug: filgrastim;   Drug: methylprednisolone;   Drug: prednisone;   Procedure: Autologous Peripheral Blood Stem Cell Transplantation

Study has passed its completion date and status has not been verified in more than two years.